Evidence map›Paper›PMID 41658773›Full record

ArticleCureus2026

Multiple Small Axillary Masses With Haloes on Ultrasound Mimicking Lymph Node Metastases in Breast Cancer: A Case Report.

Takeshi Suto, Shoji Oura

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Takeshi SutoDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.
Shoji OuraDepartment of Surgery, Kishiwada Tokushukai Hospital, Kishiwada, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 66-year-old woman had presented with various oncological events, such as in-breast recurrence, local recurrence, contralateral axillary lymph node recurrence, left ductal carcinoma in situ (DCIS) of the breast, and primary unknown metastatic neuroendocrine tumor of the liver, after neoadjuvant chemotherapy followed by breast-conserving therapy with sentinel node biopsy (SNB) for right breast cancer, i.e., invasive micro papillary carcinoma. Attending surgeons had managed these events with salvage mastectomy and re-SNB, wide resection, axillary lymph node dissection, nipple-sparing mastectomy in a thick flap manner, and partial hepatectomy, respectively. Follow-up positron emission tomography/computed tomography further showed multiple fluorodeoxyglucose uptakes in the left axilla. Ultrasound showed multiple small lesions with internal low echoes, obscured margins, and haloes. Core needle biopsy pathologically showed atypical cells growing in a trabecular and solid fashion without any lymph node structures. Under the tentative diagnosis of in-breast recurrence of the left DCIS in the preserved thick flap, the patient underwent resection of the multiple axillary lesions. All nine lesions showed estrogen receptor-positive and human epidermal growth factor type 2 receptor-negative cancer cells with a very low Ki-67 labelling index of 2%, highly resembling the pathological findings of the left DCIS. These images and pathological findings suggest that multiple small axillary masses with haloes on ultrasound are not lymph node metastases of breast cancer. Breast specialists, therefore, should develop therapeutic strategies based on the idea that multiple small axillary nodules with haloes on ultrasound have a high probability of in-breast recurrence.

Indexed as

axillary recurrenceaxillary small nodulesbreast cancerhaloesthick flap

Identifiers

PMID41658773
PMCPMC12874194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.